Value based insurance design: Maintaining a focus on health in an Era of cost containment

American Journal of Managed Care

Volumn 15, Issue 6, 2009, Pages 338-343

  Fendrick, A Mark ^b   Chernew, Michael E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH SERVICE; NOTE; PATIENT ATTITUDE; PATIENT CARE; PRIORITY JOURNAL; REIMBURSEMENT;

COST CONTROL; COST SHARING; COST-BENEFIT ANALYSIS; HUMANS; INSURANCE BENEFITS; INSURANCE, HEALTH; UNITED STATES;

EID: 67649613313     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (16)

1. Manning WG, Newhouse JP, Duan N, et al. Health insurance and the demand for medical care evidence from a randomized experiment. Am Econ Rev. 1987; 77(3):251-277.
2. Ringel JS, Hosek SD, Vollaard BA, et al. The Elasticity of Demand for Health Care: A Review of the Literature and Its Application to the Military Health System. Santa Monica, CA: RAND; 2002.
3. Siu AL, Sonnenberg FA, Manning WG, et al. Inappropriate use of hospitals in a randomized trial of health insurance plans. N Engl J Med. 1986;20(315):1259-1266. (Pubitemid 17049685)
4. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11:730-740. (Pubitemid 41608213)
5. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344-2350. (Pubitemid 38656301)
6. Trivedi AN, Rakowski W, Ayanian JZ. Effect of cost sharing on screening mammography in Medicare health plans. N Engl J Med. 2008;358(4):375-383. (Pubitemid 351159237)
7. Fendrick AM, Chernew ME. Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. Am J Manag Care. 2006;12:1-7. (Pubitemid 46053390)
8. Chernew ME, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff (Millwood). 2007;26(2):w204-w207.
9. Chernew ME, Fendrick AM. Clinically sensitive cost-sharing for prescription drugs: thinking beyond the silos. Med Care. 2009;47(5):505-507.
10. Freudenheim M. To save later, some employers are offering free drugs now. New York Times. February 21, 2007:A1.
11. Fuhrmans V. New tack on copays: cutting them. Wall Street Journal. May 8, 2007:D1.
12. Japsen B. Diabetes care: employers save money after lowering costs for employees' preventive care. Chicago Tribune. May 7, 2009.
13. Mahoney JJ. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care. 2005;11(5):S170-S176.
14. Rosen AB, Hamel MB, Weinstein MB, et al. Cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med. 2005;143(2):89-99. (Pubitemid 41001419)
15. Goldman DP, Joyce GF, Karaca-Mandic P. Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. Am J Manag Care. 2006;12(1):21-28. (Pubitemid 43139537)
16. Spaulding A, Fendrick AM, Herman WH, et al. A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial. Implement Sci. 2009;7(4):19.